Antibodies to West Nile virus infection
Sanford-Burnham Medical Research Institute
posted on 12/15/2009

Infectious Diseases - Therapeutics
West
Nile virus (WNV) is transmitted to humans from mosquito bites and can have
varied effects ranging from asymptomatic infections to a neuroinvasive
form called West Nile meningitis, which can be deadly. There is no
specific treatment for WNV infection. The current invention provides
antibodies for the treatment of WNV infection.
Lead
Inventor
Alex Strongin, Ph.D.
Strongin lab
homepage
Selected
References
List of references via
Pubmed
Patent Information
Full title: Binders to West Nile Virus Proteinase
Patent/Application #: 61/232,561
Date filed: 8-10-2009
Foreign filing: TBD
Burnham ID: 10-002
Status
Available for license
File Number: 10-002/STRONGIN*
This innovation currently is not available for online licensing. Please contact Glenn Dourado, M. Sc., MBA at Sanford-Burnham Medical Research Institute for more information.
Find more innovations
